1. Guild WR, Harrison JH, Merrill JP, Murray J. Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc 1955; 67: 167-73.
2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-83.
3. Hassanain M, Tchervenkov J, Cantarovich M, Metrakos P, Paraskevas S, Keith D, et al. Delayed graft function has an equally bad impact on deceased donor renal graft survival in both standard criteria donors and expanded criteria donors. Transplant Proc 2009; 41: 133-4.
6. Wagener G, Bezinover D, Wang C, Kroepfl E, Diaz G, Giordano C, et al. Fluid management during kidney transplantation: A consensus statement of the committee on transplant anesthesia of the american society of anesthesiologists. Transplantation 2021; 105: 1677-84.
7. Mittel AM, Wagener G. Anesthesia for kidney and pancreas transplantation. Anesthesiol Clin 2017; 35: 439-52.
8. O'Malley CM, Frumento RJ, Bennett-Guerrero E. Intravenous fluid therapy in renal transplant recipients: results of a US survey. Transplant Proc 2002; 34: 3142-5.
9. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256: 18-24. Erratum in: Ann Surg 2013; 258: 1118.
12. Maheshwari K, Turan A, Makarova N, Ma C, Esa WAS, Ruetzler K, et al. Saline versus lactated Ringer's solution: The saline or lactated Ringer's (SOLAR) trial. Anesthesiology 2020; 132: 614-24.
15. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983; 61: 1444-61.
17. Nagaoka D, Nassar Junior AP, Maciel AT, Taniguchi LU, Noritomi DT, Azevedo LCP, et al. The use of sodium-chloride difference and chloride-sodium ratio as strong ion difference surrogates in the evaluation of metabolic acidosis in critically ill patients. J Crit Care 2010; 25: 525-31.
20. O'Malley CMN, Frumento RJ, Hardy MA, Benvenisty AI, Brentjens TE, Mercer JS, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100: 1518-24.
21. Weinberg L, Harris L, Bellomo R, Ierino FL, Story D, Eastwood G, et al. Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148® on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial. Br J Anaesth 2017; 119: 606-615.
22. Hadimioglu N, Saadawy I, Saglam T, Ertug Z, Dinckan A. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg 2008; 107: 264-9.
25. Engström M, Schött U, Romner B, Reinstrup P. Acidosis impairs the coagulation: a thromboelastographic study. J Trauma 2006; 61: 624-8.
28. Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999; 88: 999-1003.
29. Haines RW, Kirwan CJ, Prowle JR. Managing chloride and bicarbonate in the prevention and treatment of acute kidney injury. Semin Nephrol 2019; 39: 473-83.
31. Shin CH, Long DR, McLean D, Grabitz SD, Ladha K, Timm FP, et al. Effects of intraoperative fluid management on postoperative outcomes: a hospital registry study. Ann Surg 2018; 267: 1084-92.
32. Halperin ML, Kamel KS. Potassium. Lancet 1998; 352: 135-40.
34. Van Aken HK, Kampmeier TG, Ertmer C, Westphal M. Fluid resuscitation in patients with traumatic brain injury: what is a SAFE approach? Curr Opin Anaesthesiol 2012; 25: 563-5.
37. Collins MG, Fahim MA, Pascoe EM, Hawley CM, Johnson DW, Varghese J, et al; BEST-Fluids Investigators; Australasian Kidney Trials Network. Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial. Lancet 2023; 402: 105-17. Erratum in: Lancet 2023; 402: 26.
38. Rehm M, Finsterer U. Treating intraoperative hyperchloremic acidosis with sodium bicarbonate or tris-hydroxymethyl aminomethane: a randomized prospective study. Anesth Analg 2003; 96: 1201-8.
39. Kim SY, Huh KH, Lee JR, Kim SH, Jeong SH, Choi YS. Comparison of the effects of normal saline versus Plasmalyte on acid-base balance during living donor kidney transplantation using the Stewart and base excess methods. Transplant Proc 2013; 45: 2191-6.
40. Potura E, Lindner G, Biesenbach P, Funk GC, Reiterer C, Kabon B, et al. An acetate-buffered balanced crystalloid versus 0.9% saline in patients with end-stage renal disease undergoing cadaveric renal transplantation: a prospective randomized controlled trial. Anesth Analg 2015; 120: 123-9.
41. González-Castro A, Ortiz-Lasa M, Rodriguez-Borregan JC, Rodrigo Calabia E, Ruiz San Millan JC, Dierssen Soto T. Influence of Proportion of normal saline administered in the perioperative period of renal transplantation on kalemia levels. Transplant Proc 2018; 50: 569-71.
42. Kolodzie K, Cakmakkaya OS, Boparai ES, Tavakol M, Feiner JR, Kim MO, et al. Perioperative normal saline administration and delayed graft function in patients undergoing kidney transplantation: A retrospective cohort study. Anesthesiology 2021; 135: 621-32. Erratum in: Anesthesiology 2022; 136: 251.
44. Do Nascimento Junior P, Dohler LE, Ogawa CMU, De Andrade LÍGM, Braz LG, M Dolo NSP. Effects of Plasma-Lyte.½ and 0.9% saline in renal function after deceased-donor kidney transplant: a randomized controlled trial. Braz J Anesthesiol 2022; 72: 711-9.
45. Cosio FG, Alamir A, Yim S, Pesavento TE, Falkenhain ME, Henry ML, et al. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998; 53: 767-72.
46. Schnuelle P, Van der Woude FJ. Perioperative fluid management in renal transplantation: a narrative review of the literature. Transpl Int 2006; 19: 947-59.
48. Holbeck S, Grände PO. Effects on capillary fluid permeability and fluid exchange of albumin, dextran, gelatin, and hydroxyethyl starch in cat skeletal muscle. Crit Care Med 2000; 28: 1089-95.
49. Limnell N, Schramko AA. Is Brain-dead donor fluid therapy with colloids associated with better kidney grafts? Exp Clin Transplant 2018; 16: 55-60.
50. Dawidson IJ, Sandor ZF, Coorpender L, Palmer B, Peters P, Lu C, et al. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation 1992; 53: 774-82.
51. Shah RB, Shah VR, Butala BP, Parikh GP. Effect of intraoperative human albumin on early graft function in renal transplantation. Saudi J Kidney Dis Transpl 2014; 25: 1148-53.
53. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41: 1211-9.
54. Davidson IJ. Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol 2006; 23: 721-38.
55. Iglesias J, Abernethy VE, Wang Z, Lieberthal W, Koh JS, Levine JS. Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol 1999; 277: F711-22.
56. Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 2010; 36: 1657-65. Erratum in: Intensive Care Med 2021; 47: 262.
57. Severs D, Hoorn EJ, Rookmaaker MB. A critical appraisal of intravenous fluids: from the physiological basis to clinical evidence. Nephrol Dial Transplant 2015; 30: 178-87.
58. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008; 51: 491-503.
59. Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg 2004; 139: 552-63.
60. Hokema F, Ziganshyna S, Bartels M, Pietsch UC, Busch T, Jonas S, et al. Is perioperative low molecular weight hydroxyethyl starch infusion a risk factor for delayed graft function in renal transplant recipients? Nephrol Dial Transplant 2011; 26: 3373-8.
61. Wu Y, Wu AS, Wang J, Tian M, Jia XY, Rui Y, et al. Effects of the novel 6% hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation. Chin Med J (Engl) 2010; 123: 3079-83.
63. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911-6.
64. Patel MS, Niemann CU, Sally MB, De La Cruz S, Zatarain J, Ewing T, et al. The impact of hydroxyethyl starch use in deceased organ donors on the development of delayed graft function in kidney transplant recipients: a propensity-adjusted analysis. Am J Transplant 2015; 15: 2152-8.
65. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-2.